FY26 consensus $17.61. Sees FY26 revenue growth 4%-6% vs. 7%-9% prior, consensus $345.81B.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COR:
- Cencora lifts 2026 outlook after OneOncology-fueled earnings jump
- COR Upcoming Earnings Report: What to Expect?
- Analyst Maintains Hold on Cencora, Citing Strong Fundamentals but Better Risk‑Reward at McKesson and Cardinal Health
- Cencora initiated with a Market Perform at William Blair
- Cencora price target lowered to $360 from $420 at Evercore ISI